These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2381266)

  • 1. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
    Umeki S; Umeki Y
    Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in warfarin concentration in blood and coagulant factors after artificial valve replacement.
    Nakamura K; Kariyazono H; Ishibashi M; Shimokawa S; Toyohira H; Taira A
    Artery; 1992; 19(6):318-43. PubMed ID: 1471922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J; Lovell G; Heubi J
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
    Fujiyama S; Morishita T; Sagara K; Sato T; Motohara K; Matsuda I
    Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acarboxy prothrombin (PIVKA II) as a tumour marker for hepatocellular carcinoma and other liver diseases.
    Mohamedein A; Yousif-Kadaru AG; Ahmed SA; Saida H; Zaki ZA; Eldin ; Fedail SS
    East Afr Med J; 1995 Sep; 72(9):584-7. PubMed ID: 7498046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acarboxy prothrombin (PIVKA-II) in cord plasma in the south of Thailand.
    Laosombat V; Kenpitak K; Wongchanchailert M; Wiriyasateinkul A
    J Med Assoc Thai; 1993 May; 76(5):278-84. PubMed ID: 8006559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver and plasma levels of descarboxyprothrombin (PIVKA II) in vitamin K deficiency in rats.
    Harauchi T; Takano K; Matsuura M; Yoshizaki T
    Jpn J Pharmacol; 1986 Apr; 40(4):491-9. PubMed ID: 3735800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIVKA-II during perioperative period in patients with hepato-biliary-pancreatic diseases.
    Kanazumi N; Takeda S; Inoue S; Ohshima K; Sugimoto H; Kaneko T; Watanabe K; Nakao A
    Hepatogastroenterology; 2000; 47(36):1695-9. PubMed ID: 11149034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation.
    Arnesen H; Smith P
    Thromb Res; 1991 Feb; 61(3):311-4. PubMed ID: 1822957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
    Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
    Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants.
    Bertina RM; van der Marel-van Nieuwkoop W; Loeliger EA
    Thromb Haemost; 1979 Dec; 42(4):1296-305. PubMed ID: 542935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
    Fujioka M; Nakashima Y; Nakashima O; Kojiro M
    Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
    Fujiyama S; Morishita T; Shibata J; Sato T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers.
    von Kries R; Shearer MJ; Widdershoven J; Motohara K; Umbach G; Göbel U
    Thromb Haemost; 1992 Oct; 68(4):383-7. PubMed ID: 1448768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K effect in low birth weight infants.
    Ogata T; Motohara K; Endo F; Kondo Y; Ikeda T; Kudo Y; Iribe K; Matsuda I
    Pediatrics; 1988 Mar; 81(3):423-7. PubMed ID: 3344186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems of anticoagulation with warfarin in hyperthyroidism.
    Kellett HA; Sawers JS; Boulton FE; Cholerton S; Park BK; Toft AD
    Q J Med; 1986 Jan; 58(225):43-51. PubMed ID: 3704105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.